BlackRock »

Black Diamond Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $15M 3.5M 4.35

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Bellevue Group
Vestal Point Capital
NEA Management Company
BlackRock
BlackRock
Vanguard Group
Ikarian Capital
Tang Capital Management
Siren
Geode Capital Management
ExodusPoint Capital Management
Citadel Advisors
Kennedy Capital Management
Point72 Asset Management

View all funds holding Black Diamond Therapeutics